Plaintiffs Allowed to Appeal Diversity Re-Removals of Cases Filed More Than One Year Earlier

Another update in the ongoing jurisdictional battles involving GlaxoSmithKline.  Howard Bashman of How Appealing reports that the Third Circuit has allowed plaintiffs to appeal the lawfulness of GSK's diversity re-removals of state court Paxil personal injury cases more than one year after the cases were filed in state court.